FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Gibson

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Jessica L Mega; Sabina A Murphy; Alexander Parkhomenko; Alexei N Plotnikov; Michal Tendera; Petr Widimsky; Eugene Braunwald; Paul Burton; Robert Gabor Kiss; C Michael Gibson
Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction: Results From the ATLAS ACS-2-TIMI-51 Trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51).
Kashish Goel; Duane S Pinto; C Michael Gibson
Association of time to reperfusion with left ventricular function and heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: a systematic review.
Yuri B Pride; Bryan J Piccirillo; C Michael Gibson
Prevalence, consequences, and implications for clinical trials of unrecognized myocardial infarction.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Gibson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jessica L Mega; Sabina A Murphy; Alexander Parkhomenko; Alexei N Plotnikov; Michal Tendera; Petr Widimsky; Eugene Braunwald; Paul Burton; Robert Gabor Kiss; C Michael Gibson
Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction: Results From the ATLAS ACS-2-TIMI-51 Trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51).
Journal of the American College of Cardiology 2013;61(18):1853-9.
2013: Kashish Goel; Duane S Pinto; C Michael Gibson
Association of time to reperfusion with left ventricular function and heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: a systematic review.
American heart journal 2013;165(4):451-67.
2013: Yuri B Pride; Bryan J Piccirillo; C Michael Gibson
Prevalence, consequences, and implications for clinical trials of unrecognized myocardial infarction.
The American journal of cardiology 2013;111(6):914-8.
2012: Anjan K Chakrabarti; C Michael Gibson; Duane S Pinto
Optimal selection of STEMI treatment strategies in the current era: benefit of transferring STEMI patients for PCI compared with administration of onsite fibrinolytic therapy.
Current opinion in cardiology 2012;27(6):651-4.
2012: Ethan J Rowin; James E Udelson; Evan Appelbaum; C Michael Gibson; Tammy S Haas; John R Lesser; Mark S Link; Warren J Manning; Barry J Maron; Martin S Maron
Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy.
The American journal of cardiology 2012;110(7):1027-32.
2012: Yuri B Pride; Cafer Zorkun; Eugene Braunwald; Robert M Califf; C Michael Gibson; Robert P Giugliano; Robert A Harrington; Vijayalakshmi Kunadian; Satishkumar Mohanavelu; L Kristin Newby
Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy.
JACC. Cardiovascular interventions 2012;5(9):927-35.
2012: Renato D Lopes; Todd J Lorenz; Michael J Mack; Rajendra H Mehta; Eric D Peterson; Eric M Reyes; Judson B Williams; Keith B Allen; Robert M Califf; T. Bruce Ferguson; C Michael Gibson; Gail E Hafley; Robert A Harrington; Nicholas T Kouchoukos; John H Alexander
Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results.
American heart journal 2012;164(3):379-386.e1.
2012: Jonathan Piccini; Charles V Pollack; Pierluigi Tricoci; Frans Van de Werf; Jennifer A White; Sana M Al-Khatib; Robert M Califf; C Michael Gibson; Robert P Giugliano; Robert A Harrington; Yuliya Lokhnygina; Rajendra H Mehta; Gilles Montalescot; L Kristin Newby
Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes.
Circulation 2012;126(1):41-9.
2012: Lakshmi Gopalakrishnan; Payal Kohli; Varun Kumar; Ujjwal Rastogi; Priyamvada Singh; C Michael Gibson
Pharmacokinetic evaluation of rivaroxaban for the treatment of acute coronary syndromes.
Expert opinion on drug metabolism & toxicology 2012;8(7):889-900.
2012: Martin S Maron; Ethan J Rowin; James E Udelson; Evan Appelbaum; Raymond H Chan; C Michael Gibson; Tammy S Haas; John R Lesser; David Lin; Jana Lindberg; Warren J Manning; Barry J Maron
Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy.
Circulation. Cardiovascular imaging 2012;5(4):441-7.
2012: Anjan K Chakrabarti; C Michael Gibson
Short- and long-term treatment with non-steroidal anti-inflammatory drugs increases risk of death or recurrent MI in those with previous MI.
Evidence-based medicine 2012;17(2):61-2.
2012: Renato D Lopes; Michael J Mack; Rajendra H Mehta; Eric D Peterson; Judson B Williams; John H Alexander; Keith B Allen; Robert M Califf; T. Bruce Ferguson; C Michael Gibson; Gail E Hafley; Robert A Harrington; Nicholas T Kouchoukos
Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery.
Circulation 2012;125(6):749-56.
2012: Anjan K Chakrabarti; Meagan Elizabeth Doherty; Cassandra Abueg; Lakshmi Gopalakrishnan; Varun Kumar; Priyamvada Singh; Weici Wang; C Michael Gibson
Admission hyperglycemia and acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabetics.
Cardiology research and practice 2012;2012():704314.
2012: Evan Appelbaum; Francesca N Delling; C Michael Gibson; Tammy S Haas; Caitlin J Harrigan; Thomas H Hauser; John R Lesser; Warren J Manning; Barry J Maron; Anne B Riley; James E Udelson; Selcuk Adabag; Martin S Maron
Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy.
Circulation. Cardiovascular imaging 2012;5(1):78-85.
2011: Duane S Pinto; Edward Ullman; Anjan K Chakrabarti; Andre Dejam; Paul D Frederick; C Michael Gibson; Timothy D Henry; Ajay J Kirtane; Dave P Miller
Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase.
Circulation 2011;124(23):2512-21.
2011: Anjan K Chakrabarti; C Michael Gibson
The SYNTAX score: usefulness, limitations, and future directions.
The Journal of invasive cardiology 2011;23(12):511-2.
2011: Vijayalakshmi Kunadian; David A Morrow; Yuri B Pride; Jacqueline Buros; Lauren N Ciaglo; C Michael Gibson
Coronary flow reserve varies depending upon the location within the artery it is assessed and the TIMI myocardial perfusion grade: a PROTECT TIMI-30 analysis.
Journal of thrombosis and thrombolysis 2011;32(4):448-52.
2011: Yuri B Pride; C Michael Gibson
Percutaneous coronary interventions in facilities without cardiac surgery on site.
Current cardiology reports 2011;13(5):432-8.
2011: Rajendra H Mehta; Eric D Peterson; John H Alexander; Robert M Califf; T. Bruce Ferguson; C Michael Gibson; Gail E Hafley; Robert A Harrington; Nicholas T Kouchoukos; Renato D Lopes; Michael J Mack
Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial.
Circulation 2011;124(3):280-8.
2011: C Michael Gibson; Jessica L Mega; Paul Burton; Shinya Goto; Freek Verheugt; Christoph Bode; Alexei Plotnikov; Xiang Sun; Nancy Cook-Bruns; Eugene Braunwald
Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome.
American heart journal 2011;161(5):815-821.e6.
2011: C Michael Gibson; Akiko Maehara; Alexandra J Lansky; Jochen Wohrle; Tom Stuckey; Rajesh Dave; David Cox; Cindy Grines; Dariusz Dudek; Gabriel Steg; Helen Parise; Steven D Wolff; Ecaterina Cristea; Gregg W Stone
Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction.
American heart journal 2011;161(3):478-486.e7.
2010: Richard C Becker; C Michael Gibson; Lisa K Jennings; David A Morrow
Antiplatelet therapy in acute coronary syndrome (ACS): applying new science to clinical decisions.
The American journal of cardiology 2010;106(8):S2-3.
2010: Timothy D Henry; C Michael Gibson; Duane S Pinto
Moving toward improved care for the patient with ST-elevation myocardial infarction: a mandate for systems of care.
Circulation. Cardiovascular quality and outcomes 2010;3(5):441-3.
2010: Yuri B Pride; Jennifer L Giuseffi; Satishkumar Mohanavelu; Caitlin J Harrigan; Warren J Manning; C Michael Gibson; Evan Appelbaum
Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarct.
The American journal of cardiology 2010;106(5):635-40.
2010: Robert P Giugliano; Roberto R Giraldez; David A Morrow; Elliott M Antman; C Michael Gibson; Satishkumar Mohanavelu; Sabina A Murphy; Carolyn H McCabe; Eugene Braunwald
Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
European heart journal 2010;31(17):2103-10.
2010: Yuri B Pride; Patricia Tung; Satishkumar Mohanavelu; Cafer Zorkun; Stephen D Wiviott; Elliott M Antman; Robert P Giugliano; Eugene Braunwald; C Michael Gibson
Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy.
JACC. Cardiovascular interventions 2010;3(8):806-11.
2010: Sergio Leonardi; Sunil V Rao; Robert A Harrington; Deepak L Bhatt; C Michael Gibson; Matthew T Roe; Janusz Kochman; Kurt Huber; Uwe Zeymer; Mina Madan; Daniel D Gretler; Matthew W McClure; Gayle E Paynter; Vivian Thompson; Robert C Welsh
Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y(12)-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI).
American heart journal 2010;160(1):65-72.
2010: Matthew W Sherwood; David A Morrow; Benjamin M Scirica; Songtao Jiang; Christoph Bode; Nader Rifai; Robert E Gerszten; C Michael Gibson; Christopher P Cannon; Eugene Braunwald; Marc S Sabatine
Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28.
American heart journal 2010;159(6):964-971.e1.
2010: Michael Hudson; Adam Greenbaum; Laura Brenton; C Michael Gibson; Robert Siegel; Lisa R Reeves; Miguel Fiol Sala; George McKendall; Jorge Bluguermann; Debra Echt; Erik Ohman; W Douglas Weaver
Adjunctive transcutaneous ultrasound with thrombolysis: results of the PLUS (Perfusion by ThromboLytic and UltraSound) trial.
JACC. Cardiovascular interventions 2010;3(3):352-9.
2010: C Michael Gibson; Yuri B Pride
Myocardial infarct size reduction with pexelizumab: the role of chance is patently clear.
JACC. Cardiovascular imaging 2010;3(1):61-3.
2009: Deepak L Bhatt; A Michael Lincoff; C Michael Gibson; Gregg W Stone; Steven McNulty; Gilles Montalescot; Neal S Kleiman; Shaun G Goodman; Harvey D White; Kenneth W Mahaffey; Charles V Pollack; Steven V Manoukian; Petr Widimsky; Derek P Chew; Fernando Cura; Ivan Manukov; Frantisek Tousek; M Zubair Jafar; Jaspal Arneja; Simona Skerjanec; Robert A Harrington
Intravenous platelet blockade with cangrelor during PCI.
The New England journal of medicine 2009;361(24):2330-41.
2009: Robert A Harrington; Gregg W Stone; Steven McNulty; Harvey D White; A Michael Lincoff; C Michael Gibson; Charles V Pollack; Gilles Montalescot; Kenneth W Mahaffey; Neal S Kleiman; Shaun G Goodman; Maged Amine; Dominick J Angiolillo; Richard C Becker; Derek P Chew; William J French; Franz Leisch; Keyur H Parikh; Simona Skerjanec; Deepak L Bhatt
Platelet inhibition with cangrelor in patients undergoing PCI.
The New England journal of medicine 2009;361(24):2318-29.
2009: C Michael Gibson; Yuri B Pride; Claudia P Hochberg; Sarah Sloan; Marc S Sabatine; Christopher P Cannon
Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
Journal of the American College of Cardiology 2009;54(24):2290-5.
2009: Jeffrey S Berger; Matthew T Roe; C Michael Gibson; Rakhi Kilaru; Cynthia L Green; Laura Melton; James D Blankenship; D Christopher Metzger; Christopher B Granger; Daniel D Gretler; Cindy L Grines; Kurt Huber; Uwe Zeymer; Pawel Buszman; Robert A Harrington; Paul W Armstrong
Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial.
American heart journal 2009;158(6):998-1004.e1.
2009: Sunil V Rao; John Eikelboom; Ph Gabriel Steg; A Michael Lincoff; William S Weintraub; Jean-Pierre Bassand; A Koneti Rao; C Michael Gibson; John L Petersen; Roxana Mehran; Steven V Manoukian; Richard Charnigo; Kerry L Lee; Mauro Moscucci; Robert A Harrington
Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group.
American heart journal 2009;158(6):881-886.e1.
2009: Yuri B Pride; John G Canto; Paul D Frederick; C Michael Gibson
Outcomes among patients with ST-segment-elevation myocardial infarction presenting to interventional hospitals with and without on-site cardiac surgery.
Circulation. Cardiovascular quality and outcomes 2009;2(6):574-82.
2009: Yuri B Pride; John G Canto; Paul D Frederick; C Michael Gibson
Outcomes among patients with non-ST-segment elevation myocardial infarction presenting to interventional hospitals with and without on-site cardiac surgery.
JACC. Cardiovascular interventions 2009;2(10):944-52.
2009: Yuri B Pride; Stephen D Wiviott; Jacqueline Buros; Cafer Zorkun; M Umer Tariq; Elliott M Antman; Eugene Braunwald; C Michael Gibson
Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
American heart journal 2009;158(3):e21-6.
2009: Yuri B Pride; Evan Appelbaum; Erin E Lord; Sarah Sloan; Christopher P Cannon; Marc S Sabatine; C Michael Gibson
Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
The American journal of cardiology 2009;104(4):475-9.
2009: Renato D Lopes; Gail E Hafley; Keith B Allen; T Bruce Ferguson; eric peterson; Robert A Harrington; Rajendra H Mehta; C Michael Gibson; Michael J Mack; Nicholas T Kouchoukos; Robert M Califf; John H Alexander
Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery.
The New England journal of medicine 2009;361(3):235-44.
2009: C Michael Gibson; Yuri B Pride; Jacqueline Buros; Lauren N Ciaglo; David A Morrow; Benjamin M Scirica; Peter H Stone
Timing and duration of myocardial ischemia on Holter monitoring following percutaneous coronary intervention and their association with clinical outcomes (a PROTECT-TIMI 30 Substudy Analysis).
The American journal of cardiology 2009;104(1):36-40.
2009: Deepak L Bhatt; eric peterson; Robert A Harrington; Fang-Shu Ou; Christopher P Cannon; C Michael Gibson; Neal S Kleiman; Ralph G Brindis; W Frank Peacock; Sorin J Brener; Venu Menon; Sidney C Smith; Charles V Pollack; W Brian Gibler; Erik Ohman; Matthew T Roe
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes.
European heart journal 2009;30(10):1195-202.
2009: Patricia Tung; Stephen D Wiviott; Christopher P Cannon; Sabina A Murphy; Carolyn H McCabe; C Michael Gibson
Seasonal variation in lipids in patients following acute coronary syndrome on fixed doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22 [PROVE IT-TIMI 22] Study).
The American journal of cardiology 2009;103(8):1056-60.
2009: Tracy Y Wang; Min Zhang; Yuling Fu; Paul W Armstrong; L Kristin Newby; C Michael Gibson; David J Moliterno; Frans Van de Werf; Harvey D White; Robert A Harrington; Matthew T Roe
Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography.
American heart journal 2009;157(4):716-23.
2009: Vijayalakshmi Kunadian; Caitlin Harrigan; Cafer Zorkun; Alexandra M Palmer; Katherine J Ogando; Leah H Biller; Erin E Lord; Scott P Williams; Michelle E Lew; Lauren N Ciaglo; Jacqueline Buros; Susan J Marble; William J Gibson; C Michael Gibson
Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years.
Journal of thrombosis and thrombolysis 2009;27(3):316-28.
2009: James E Tcheng; Ing Haan Lim; Shankar Srinivasan; Joseph Jozic; C Michael Gibson; J Conor O'Shea; JA Puma; Daniel I Simon
Stent parameters predict major adverse clinical events and the response to platelet glycoprotein IIb/IIIa blockade: findings of the ESPRIT trial.
Circulation. Cardiovascular interventions 2009;2(1):43-51.
2008: Shaheeda Ahmed; Christopher P Cannon; Robert P Giugliano; Sabina A Murphy; David A Morrow; Elliott M Antman; Eugene Braunwald; C Michael Gibson
The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes.
International journal of cardiology 2008;131(1):105-12.
2008: C Michael Gibson
Antiplatelet therapy: anti-ischemic benefits versus bleeding risk.
Journal of interventional cardiology 2008;21 Suppl 1():S3-9.
2008: C Michael Gibson; Barry Watkins; Kathy Merlo
Introduction. Key issues surrounding the treatment of acute coronary syndromes (ACS).
Journal of interventional cardiology 2008;21 Suppl 1():S1-2.
2008: eric peterson; Bimal R Shah; Lori Parsons; Charles V Pollack; William J French; John G Canto; C Michael Gibson; William J Rogers
Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006.
American heart journal 2008;156(6):1045-55.
2008: C Michael Gibson; Yuri B Pride; Paul D Frederick; Charles V Pollack; John G Canto; Alan J Tiefenbrunn; W Douglas Weaver; Costas T Lambrew; William J French; eric peterson; William J Rogers
Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006.
American heart journal 2008;156(6):1035-44.
2008: Vijayalakshmi Kunadian; Cafer Zorkun; Scott P Williams; Leah H Biller; Alexandra M Palmer; Katherine J Ogando; Michelle E Lew; Navin Nethala; William J Gibson; Susan J Marble; Jacqueline Buros; C Michael Gibson
Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction.
Journal of thrombosis and thrombolysis 2008;26(3):234-42.
2008: Rajendra H Mehta; Gail E Hafley; C Michael Gibson; Robert A Harrington; eric peterson; Michael J Mack; Nicholas T Kouchoukos; Robert M Califf; T. Bruce Ferguson; John H Alexander
Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgery.
The Journal of thoracic and cardiovascular surgery 2008;136(5):1149-55.
2008: Martin S Maron; Evan Appelbaum; Caitlin J Harrigan; Jacqueline Buros; C Michael Gibson; Connie Hanna; John R Lesser; James E Udelson; Warren J Manning; Barry J Maron
Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.
Circulation. Heart failure 2008;1(3):184-91.
2008: James M Yau; John H Alexander; Gail E Hafley; Kenneth W Mahaffey; Michael J Mack; Nicholas T Kouchoukos; Abhinav Goyal; eric peterson; C Michael Gibson; Robert M Califf; Robert A Harrington; T. Bruce Ferguson
Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV).
The American journal of cardiology 2008;102(5):546-51.
2008: C Michael Gibson; Cafer Zorkun; Vijayalakshmi Kunadian
Intracoronary administration of abciximab in ST-elevation myocardial infarction.
Circulation 2008;118(1):6-8.
2008: Ioanna Kosmidou; Dimitrios Karmpaliotis; Ajay J Kirtane; Hal V Barron; C Michael Gibson
Vascular endothelial growth factors in pulmonary edema: an update.
Journal of thrombosis and thrombolysis 2008;25(3):259-64.
2008: C Michael Gibson; Yuri B Pride; Jacqueline Buros; Vijayalakshmi Kunadian; Matthew C Southard; Caitlin J Harrigan; Lauren N Ciaglo; Marc S Sabatine; Christopher P Cannon; Eugene Braunwald
Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy.
The American journal of cardiology 2008;101(9):1232-8.
2008: A Selcuk Adabag; Barry J Maron; Evan Appelbaum; Caitlin J Harrigan; Jacqueline Buros; C Michael Gibson; John R Lesser; Constance A Hanna; James E Udelson; Warren J Manning; Martin S Maron
Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.
Journal of the American College of Cardiology 2008;51(14):1369-74.
2008: Michael J Rinaldi; Ajay J Kirtane; Robert N Piana; Ronald P Caputo; Paul C Gordon; JJ Lopez; Harold L Dauerman; Thomas Ryan; Francis J Kiernan; Donald E Cutlip; Kalon K L Ho; C Michael Gibson; Sabina A Murphy; David J Cohen
Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.
American heart journal 2008;155(4):654-60.
2008: Michelle O'Donoghue; David A Morrow; Christopher P Cannon; Wei Guo; Sabina A Murphy; C Michael Gibson; Marc S Sabatine
Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy.
European heart journal 2008;29(8):984-91.
2008: Caitlin J Harrigan; Evan Appelbaum; Barry J Maron; Jacqueline Buros; C Michael Gibson; John R Lesser; James E Udelson; Warren J Manning; Martin S Maron
Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
The American journal of cardiology 2008;101(5):668-73.
2008: C Michael Gibson; Yuri B Pride; Jacqueline Buros; Erin Lord; Amy Shui; Sabina A Murphy; Duane S Pinto; Peter Zimetbaum; Marc S Sabatine; Christopher P Cannon; Mark E Josephson
Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2008;51(5):546-51.
2008: Gui Fu Wu; Joanna J Wykrzykowska; Jamal S Rana; Duane S Pinto; C Michael Gibson; Jian Li; Frank W Sellke; Roger J Laham
Effects of B-type natriuretic peptide (nesiritide) on coronary epicardial arteries, systemic vasculature and microvessels.
The Journal of invasive cardiology 2008;20(2):76-80.
2008: Duane S Pinto; Ajay J Kirtane; Yuri B Pride; Sabina A Murphy; Marc S Sabatine; Christopher P Cannon; C Michael Gibson
Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study).
The American journal of cardiology 2008;101(3):303-7.
2008: Stephen A Olenchock; Dimitri Karmpaliotis; William Gibson; Sabina A Murphy; Matthew C Southard; Lauren N Ciaglo; Jacqueline Buros; Michael J Mack; John H Alexander; Robert A Harrington; Robert M Califf; Nicholas T Kouchoukos; T. Bruce Ferguson; C Michael Gibson
Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters.
The Annals of thoracic surgery 2008;85(2):520-4.
2008: C Michael Gibson; Sabina A Murphy; Yuri B Pride; Ajay J Kirtane; Julian M Aroesty; Erica B Stein; Lauren N Ciaglo; Matthew C Southard; Marc S Sabatine; Christopher P Cannon; Eugene Braunwald
Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
American heart journal 2008;155(1):133-9.
2008: Pierre Voisine; Audrey Rosinberg; Joanna J Wykrzykowska; Yulia Shamis; Gui Fu Wu; Evan Appelbaum; Jian Li; Frank W Sellke; Duane Pinto; C Michael Gibson; Eduardo Mitrani; Roger J Laham
Skin-derived microorgan autotransplantation as a novel approach for therapeutic angiogenesis.
American journal of physiology. Heart and circulatory physiology 2008;294(1):H213-9.
2007: Robert W Yeh; Stephen D Wiviott; Robert P Giugliano; David A Morrow; Amy Shui; Jie Qin; Benjamin M Scirica; James E Bradner; Ik-Kyung Jang; C Michael Gibson; Elliott M Antman
Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes.
The American journal of cardiology 2007;100(12):1734-8.
2007: Stephen D Wiviott; Eugene Braunwald; Carolyn H McCabe; Gilles Montalescot; Witold Ruzyllo; Shmuel Gottlieb; Franz-Joseph Neumann; Diego Ardissino; Stefano De Servi; Sabina A Murphy; Jeffrey Riesmeyer; Govinda J Weerakkody; C Michael Gibson; Elliott M Antman
Prasugrel versus clopidogrel in patients with acute coronary syndromes.
The New England journal of medicine 2007;357(20):2001-15.
2007: Adam B Greenbaum; Erik Ohman; C Michael Gibson; Steven Borzak; Amanda L Stebbins; Mei Lu; Michel R Le May; Jill E Stankowski; Hakan Emanuelsson; W Douglas Weaver
Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial.
American heart journal 2007;154(4):702-9.
2007: Susan B Yeon; Adeel Sabir; Melvin Clouse; Pedro Martinezclark; Dana C Peters; Thomas H Hauser; C Michael Gibson; Reza Nezafat; David Maintz; Warren J Manning; René M Botnar
Delayed-enhancement cardiovascular magnetic resonance coronary artery wall imaging: comparison with multislice computed tomography and quantitative coronary angiography.
Journal of the American College of Cardiology 2007;50(5):441-7.
2007: Saumil R Shah; Claudia P Hochberg; Duane S Pinto; C Michael Gibson
Reperfusion strategies for ST-elevation myocardial infarction.
Current cardiology reports 2007;9(4):281-8.
2007: C Michael Gibson; Jacqueline Buros; Lauren N Ciaglo; Matthew C Southard; Shaun Takao; Caitlin Harrigan; Jason Filopei; Michelle Lew; Susan J Marble; Sabina A Murphy; Mauricio G. Cohen
Impact of iodinated contrast injections on percent diameter coronary arterial stenosis and implications for trials of intracoronary pharmacotherapies in patients with ST-elevation myocardial infarction.
The American journal of cardiology 2007;100(1):13-7.
2007: Benjamin A Steinberg; Nazanin Moghbeli; Jacqueline Buros; Mikhail Ruda; Alexander Parkhomenko; B Soma Raju; Armando García-Castillo; Marianna Janion; José Carlos Nicolau; Keith A A Fox; David A Morrow; C Michael Gibson; Elliott M Antman
Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial.
American heart journal 2007;154(1):54-61.
2007: C Michael Gibson; Yuli Ten; Sabina A Murphy; Lauren N Ciaglo; Matthew C Southard; A Michael Lincoff; Ron Waksman
Association of prerandomization anticoagulant switching with bleeding in the setting of percutaneous coronary intervention (A REPLACE-2 analysis).
The American journal of cardiology 2007;99(12):1687-90.
2007: C Michael Gibson; Sabina A Murphy; Gilles Montalescot; David A Morrow; Diego Ardissino; Marc Cohen; Dietrich C Gulba; Oscar H Kracoff; Basil S. Lewis; Nathan Roguin; Elliott M Antman; Eugene Braunwald
Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
Journal of the American College of Cardiology 2007;49(23):2238-46.
2007: Pierluigi Tricoci; eric peterson; Anita Y Chen; L Kristin Newby; Robert A Harrington; Adam B Greenbaum; Chistopher P Cannon; C Michael Gibson; James W Hoekstra; Charles V Pollack; Erik Ohman; W Brian Gibler; Matthew T Roe
Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE).
The American journal of cardiology 2007;99(10):1389-93.
2007: Sinjin Lee; C Michael Gibson
Enoxaparin in acute coronary syndromes.
Expert review of cardiovascular therapy 2007;5(3):387-99.
2007: Dimitrios Karmpaliotis; Ajay J Kirtane; Christopher P Ruisi; Tamar Polonsky; Atul Malhotra; Daniel Talmor; Ioanna Kosmidou; Petr Jarolim; James A de Lemos; Marc S Sabatine; C Michael Gibson; David Morrow
Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema.
Chest 2007;131(4):964-71.
2007: Kausik K Ray; Christopher P Cannon; David A Morrow; Ajay J Kirtane; Jacqueline Buros; Nader Rifai; Carolyn H McCabe; C Michael Gibson; Eugene Braunwald
Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18.
European heart journal 2007;28(7):806-13.
2007: C Michael Gibson; Lauren N Ciaglo; Matthew C Southard; Shaun Takao; Caitlin Harrigan; Jason Lewis; Jason Filopei; Michelle Lew; Sabina A Murphy; Jacqueline Buros
Diagnostic and prognostic value of ambulatory ECG (Holter) monitoring in patients with coronary heart disease: a review.
Journal of thrombosis and thrombolysis 2007;23(2):135-45.
2007: Abhinav Goyal; John H Alexander; Gail E Hafley; Stacy H Graham; Rajendra H Mehta; Michael J Mack; Randall K Wolf; Lawrence H Cohn; Nicholas T Kouchoukos; Robert A Harrington; Daniel Gennevois; C Michael Gibson; Robert M Califf; T. Bruce Ferguson; eric peterson
Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
The Annals of thoracic surgery 2007;83(3):993-1001.
2006: Duane S Pinto; Ajay J Kirtane; Brahmajee K Nallamothu; Sabina A Murphy; David J Cohen; Roger J Laham; Donald E Cutlip; Eric R Bates; Paul D Frederick; Dave P Miller; Joseph P Carrozza; Elliott M Antman; Christopher P Cannon; C Michael Gibson
Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy.
Circulation 2006;114(19):2019-25.
2006: C Michael Gibson; Ajay J Kirtane; David A Morrow; Theresa M Palabrica; Sabina A Murphy; Peter H Stone; Benjamin M Scirica; Lisa K Jennings; Howard C Herrmann; David J Cohen; Carolyn H McCabe; Eugene Braunwald
Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
American heart journal 2006;152(4):756-61.
2006: C Michael Gibson; Ajay J Kirtane; Sabina A Murphy; Steve Rohrbeck; Venu Menon; Jeffrey Lins; Samer Kazziha; Ivan Rokos; Nicolas W Shammas; Theresa M Palabrica; Polly Fish; Carolyn H McCabe; Eugene Braunwald
Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial.
American heart journal 2006;152(4):668-75.
2006: Manesh R Patel; Anita Y Chen; eric peterson; L Kristin Newby; Charles V Pollack; Ralph G Brindis; C Michael Gibson; Neal S Kleiman; Jorge F Saucedo; Deepak L Bhatt; W Brian Gibler; Erik Ohman; Robert A Harrington; Matthew T Roe
Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative.
American heart journal 2006;152(4):641-7.
2006: Stephen D Wiviott; Elliott M Antman; C Michael Gibson; Gilles Montalescot; Jeffrey Riesmeyer; Govinda J Weerakkody; Kenneth J Winters; Jeffrey W Warmke; Carolyn H McCabe; Eugene Braunwald
Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
American heart journal 2006;152(4):627-35.
2006: Kausik K Ray; Richard G Bach; Christopher P Cannon; Richard Cairns; Ajay J Kirtane; Stephen D Wiviott; Carolyn H McCabe; Eugene Braunwald; C Michael Gibson
Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS.
European heart journal 2006;27(19):2310-6.
2006: C Michael Gibson; Hung Q Ly; Sabina A Murphy; Lauren N Ciaglo; Matthew C Southard; Erica B Stein; Jacqueline Buros; Marc S Sabatine; Christopher P Cannon
Usefulness of clopidogrel in abolishing the increased risk of reinfarction associated with higher platelet counts in patients with ST-elevation myocardial infarction (results from CLARITY-TIMI 28).
The American journal of cardiology 2006;98(6):761-3.
2006: Aaron D Kugelmass; Saihari Sadanandan; Nasser Lakkis; Peter M DiBattiste; Debbie H Robertson; Laura A Demopoulos; C Michael Gibson; William S Weintraub; Sabina A Murphy; Christopher P Cannon
Early invasive strategy improves outcomes in patients with acute coronary syndrome with previous coronary artery bypass graft surgery: a report from TACTICS-TIMI 18.
Critical pathways in cardiology 2006;5(3):167-72.
2006: Ajay J Kirtane; Jonathan J Vafai; Sabina A Murphy; Julian M Aroesty; Marc S Sabatine; Christopher P Cannon; C Michael Gibson
Angiographically evident thrombus following fibrinolytic therapy is associated with impaired myocardial perfusion in STEMI: a CLARITY-TIMI 28 substudy.
European heart journal 2006;27(17):2040-5.
2006: C Michael Gibson; Cafer Zorkun; Peter Molhoek; Krzysztof Zmudka; Mark Greenberg; Hiltrud Mueller; Jan Wesdorp; Hans Louwerenburg; Alan Niederman; Jaap Westenburg; Mahesh Bikkina; John Batty; Jobst de Winter; Sabina A Murphy; Carolyn H McCabe
Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: results of the TIMI 31 trial.
Journal of thrombosis and thrombolysis 2006;22(1):13-21.
2006: Benjamin M Scirica; Marc S Sabatine; David A Morrow; C Michael Gibson; Sabina A Murphy; Stephen D Wiviott; Robert P Giugliano; Carolyn H McCabe; Christopher P Cannon; Eugene Braunwald
The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study.
Journal of the American College of Cardiology 2006;48(1):37-42.
2006: Hung Q Ly; Ajay J Kirtane; Sabina A Murphy; Jacqueline Buros; Christopher P Cannon; Eugene Braunwald; C Michael Gibson
Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials).
The American journal of cardiology 2006;98(1):1-5.
2006: Ajay J Kirtane; Gregory Piazza; Sabina A Murphy; Daniela Budiu; David A Morrow; David J Cohen; Eric Peterson; Nasser Lakkis; Howard C Herrmann; Theresa M Palabrica; C Michael Gibson
Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial.
Journal of the American College of Cardiology 2006;47(12):2374-9.
2006: C Michael Gibson; David A Morrow; Sabina A Murphy; Theresa M Palabrica; Lisa K Jennings; Peter H Stone; Henry H Lui; Thomas Bulle; Nasser Lakkis; Richard Kovach; David J Cohen; Polly Fish; Carolyn H McCabe; Eugene Braunwald
A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial.
Journal of the American College of Cardiology 2006;47(12):2364-73.
2006: Duane S Pinto; Matthew C Southard; Lauren N Ciaglo; C Michael Gibson
Door-to-balloon delays with percutaneous coronary intervention in ST-elevation myocardial infarction.
American heart journal 2006;151(6 Suppl):S24-9.
2006: C Michael Gibson; Dimitrios Karmpaliotis; Ioanna Kosmidou; Sabina A Murphy; Ajay J Kirtane; Daniela Budiu; Kausik K Ray; Howard C Herrmann; Nasser Lakkis; Richard Kovach; William J French; James Blankenship; Henry H Lui; Theresa M Palabrica; Lisa K Jennings; David J Cohen; David A Morrow
Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome.
The American journal of cardiology 2006;97(10):1473-7.
2006: Raphaëlle Dumaine; C Michael Gibson; Sabina A Murphy; Matthew C Southard; Hung Q Ly; Carolyn H McCabe; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Eugene Braunwald
Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndrome.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(5):315-22.
2006: Andrew T Yan; C Michael Gibson; Eric Larose; Nagesh S Anavekar; Sui Tsang; Scott D Solomon; Glenn Reynolds; Raymond Y Kwong
Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging.
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 2006;8(6):831-7.
2006: Marc S Sabatine; David A Morrow; Carolyn H McCabe; Elliott M Antman; C Michael Gibson; Christopher P Cannon
Combination of quantitative ST deviation and troponin elevation provides independent prognostic and therapeutic information in unstable angina and non-ST-elevation myocardial infarction.
American heart journal 2006;151(1):25-31.
2005: Karen P Alexander; Anita Y Chen; Matthew T Roe; L Kristin Newby; C Michael Gibson; Nancy M Allen LaPointe; Charles V Pollack; W Brian Gibler; Erik Ohman; eric peterson
Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.
JAMA : the journal of the American Medical Association 2005;294(24):3108-16.
2005: Marc S Sabatine; David A Morrow; Gilles Montalescot; Mikael Dellborg; Jose L Leiva-Pons; Mátyás Keltai; Sabina A Murphy; Carolyn H McCabe; C Michael Gibson; Christopher P Cannon; Elliott M Antman; Eugene Braunwald
Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
Circulation 2005;112(25):3846-54.
2005: Duane S Pinto; Ajay J Kirtane; Nicholas A Ruocco; Albert J Deibele; Amy Shui; Jacqueline Buros; Sabina A Murphy; C Michael Gibson
Administration of intracoronary eptifibatide during ST-elevation myocardial infarction.
The American journal of cardiology 2005;96(11):1494-7.
2005: Kausik K Ray; Christopher P Cannon; Richard Cairns; David A Morrow; Nader Rifai; Ajay J Kirtane; Carolyn H McCabe; Allan M Skene; C Michael Gibson; Paul M Ridker; Eugene Braunwald
Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.
Journal of the American College of Cardiology 2005;46(8):1417-24.
2005: John H Alexander; T. Bruce Ferguson; Diane M Joseph; Michael J Mack; Randall K Wolf; C Michael Gibson; Daniel Gennevois; Todd J Lorenz; Robert A Harrington; eric peterson; Kerry L Lee; Robert M Califf; Nicholas T Kouchoukos
The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics.
American heart journal 2005;150(4):643-9.
2005: Nazanin Moghbeli; Ajay J Kirtane; Kausik K Ray; Sabina A Murphy; C Michael Gibson; Eugene Braunwald; Christopher P Cannon
C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial).
The American journal of cardiology 2005;96(5):635-8.
2005: Ajay J Kirtane; David M Leder; Sushrut S Waikar; Glenn M Chertow; Kausik K Ray; Duane S Pinto; Dimitrios Karmpaliotis; Andrew J Burger; Sabina A Murphy; Christopher P Cannon; Eugene Braunwald; C Michael Gibson
Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates.
Journal of the American College of Cardiology 2005;45(11):1781-6.
2005: Robert P Giugliano; L Kristin Newby; Robert A Harrington; C Michael Gibson; Frans Van de Werf; Paul Armstrong; Gilles Montalescot; James Gilbert; John Strony; Robert M Califf; Eugene Braunwald
The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome--study design and rationale.
American heart journal 2005;149(6):994-1002.
2005: Allen Jeremias; C Michael Gibson
Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded.
Annals of internal medicine 2005;142(9):786-91.
2005: Jessica L Mega; David A Morrow; Marc S Sabatine; Xue-Qiao Zhao; Steven M Snapinn; Peter M DiBattiste; C Michael Gibson; Elliott M Antman; Eugene Braunwald; Pierre Théroux
Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial.
American heart journal 2005;149(5):846-50.
2005: Marc S Sabatine; David A Morrow; Robert P Giugliano; Paul B J Burton; Sabina A Murphy; Carolyn H McCabe; C Michael Gibson; Eugene Braunwald
Association of hemoglobin levels with clinical outcomes in acute coronary syndromes.
Circulation 2005;111(16):2042-9.
2005: Marc S Sabatine; Christopher P Cannon; C Michael Gibson; Jose L López-Sendón; Gilles Montalescot; Pierre Theroux; Marc J Claeys; Frank Cools; Karen A Hill; Allan M Skene; Carolyn H McCabe; Eugene Braunwald
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
The New England journal of medicine 2005;352(12):1179-89.
2005: Marc S Sabatine; Gavin J Blake; Mark H Drazner; David A Morrow; Benjamin M Scirica; Sabina A Murphy; Carolyn H McCabe; William S Weintraub; C Michael Gibson; Christopher P Cannon
Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatment.
Circulation 2005;111(10):1217-24.
2005: Kausik K Ray; David A Morrow; C Michael Gibson; Sabina Murphy; Elliott M Antman; Eugene Braunwald
Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy.
European heart journal 2005;26(5):440-6.
2005: Marc S Sabatine; Carolyn H McCabe; C Michael Gibson; Christopher P Cannon
Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial.
American heart journal 2005;149(2):227-33.
2005: C Michael Gibson; Ajay J Kirtane; Keith Boundy; Hung Ly; Dimitrios Karmpaliotis; Sabina A Murphy; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Eugene Braunwald
Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients.
Journal of the American College of Cardiology 2005;45(3):357-62.
2005: Hung Q Ly; Ajay J Kirtane; Jacqueline Buros; Robert P Giugliano; Jeffrey J Popma; Elliott M Antman; Robert A Harrington; Erik Ohman; C Michael Gibson
Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction.
The American journal of cardiology 2005;95(3):383-6.
2005: Ajay J Kirtane; Ioanna Kosmidou; Dimitrios Karmpaliotis; Sabina A Murphy; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Eugene Braunwald; C Michael Gibson
Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy.
The American journal of cardiology 2005;95(3):337-42.
2005: Ajay J Kirtane; Pedro Martinezclark; Aref M Rahman; Kausik K Ray; Dimitrios Karmpaliotis; Sabina A Murphy; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Matthew T Roe; Robert A Harrington; Erik Ohman; Eugene Braunwald; C Michael Gibson
Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2005;45(2):321-3.
2005: Ajay J Kirtane; Aaron Weisbord; Dimitrios Karmpaliotis; Sabina A Murphy; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Erik Ohman; Matthew T Roe; Eugene Braunwald; C Michael Gibson
Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction.
The American journal of cardiology 2005;95(2):224-7.
2004: Minang P Turakhia; Sabina A Murphy; Tina L Pinto; Elliott M Antman; Robert P Giugliano; Christopher P Cannon; Eugene Braunwald; C Michael Gibson
Association of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction.
The American journal of cardiology 2004;94(11):1406-10.
2004: C Michael Gibson; Raphaelle L Dumaine; Eli V Gelfand; Sabina A Murphy; David A Morrow; Stephen D Wiviott; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Eugene Braunwald
Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials.
European heart journal 2004;25(22):1998-2005.
2004: Dimitrios Karmpaliotis; Minang P Turakhia; Ajay J Kirtane; Sabina A Murphy; Ioanna Kosmidou; David A Morrow; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Eugene Braunwald; C Michael Gibson
Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction.
The American journal of cardiology 2004;94(9):1113-7.
2004: C Michael Gibson
NRMI and current treatment patterns for ST-elevation myocardial infarction.
American heart journal 2004;148(5 Suppl):S29-33.
2004: C Michael Gibson; Sabina A Murphy; Ajay J Kirtane; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Eugene Braunwald
Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2004;44(5):980-7.
2004: Stephen D Wiviott; David A Morrow; Paul D Frederick; Robert P Giugliano; C Michael Gibson; Carolyn H McCabe; Christopher P Cannon; Elliott M Antman; Eugene Braunwald
Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2004;44(4):783-9.
2004: C Michael Gibson; Kanwar P Singh; Sabina A Murphy; Peter M DiBattiste; Laura A Demopoulos; Christopher P Cannon; Eugene Braunwald
Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy).
The American journal of cardiology 2004;94(4):492-4.
2004: C Michael Gibson; Lisa K Jennings; Sabina A Murphy; David P Lorenz; Robert P Giugliano; Robert A Harrington; Shila Cholera; Rajini Krishnan; Robert M Califf; Eugene Braunwald
Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy.
Circulation 2004;110(6):679-84.
2004: C Michael Gibson; Sabina A Murphy; David A Morrow; Julian M Aroesty; Raymond J Gibbons; Steven G Gourlay; Hal V Barron; Robert P Giugliano; Elliott M Antman; Eugene Braunwald
Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction.
American heart journal 2004;148(2):336-40.
2004: Jessica L Mega; David A Morrow; James A De Lemos; Marc S Sabatine; Sabina A Murphy; Nader Rifai; C Michael Gibson; Elliott M Antman; Eugene Braunwald
B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Journal of the American College of Cardiology 2004;44(2):335-9.
2004: Graham S Gardner; Daniel R Frisch; Sabina A Murphy; Ajay J Kirtane; Robert P Giugliano; Elliott M Antman; Eugene Braunwald; C Michael Gibson
Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries.
The American journal of cardiology 2004;94(2):178-81.
2004: C Michael Gibson; Brian Bigelow; David James; Micah R Tepper; Sabina A Murphy; Ajay J Kirtane; Robert P Giugliano; Christopher P Cannon; Elliott M Antman
Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction.
The American journal of cardiology 2004;94(1):108-11.
2004: C Michael Gibson; Albert Schömig
Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion.
Circulation 2004;109(25):3096-105.
2004: Ajay J Kirtane; Anh Bui; Sabina A Murphy; Dimitrios Karmpaliotis; Ioanna Kosmidou; Keith Boundy; Aref Rahman; Duane S Pinto; Julian M Aroesty; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; C Michael Gibson
Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction.
Journal of thrombosis and thrombolysis 2004;17(3):177-84.
2004: Robert P Giugliano; Marc S Sabatine; C Michael Gibson; Matthew T Roe; Robert A Harrington; Sabina A Murphy; David A Morrow; Elliott M Antman; Eugene Braunwald
Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion.
The American journal of cardiology 2004;93(11):1362-7, A5-6.
2004: C Michael Gibson; Juhana Karha; Robert P Giugliano; Matthew T Roe; Sabina A Murphy; Robert A Harrington; Cynthia L Green; Marc J Schweiger; Jerry S Miklin; Kenneth W Baran; Sebastian T Palmeri; Eugene Braunwald; Mitchell W Krucoff
Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction.
American heart journal 2004;147(5):847-52.
2004: C Michael Gibson; Juhana Karha; Sabina A Murphy; James A de Lemos; David A Morrow; Robert P Giugliano; Matthew T Roe; Robert A Harrington; Christopher P Cannon; Elliott M Antman; Robert M Califf; Eugene Braunwald
Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction.
Journal of the American College of Cardiology 2004;43(7):1170-6.
2004: Matthew T Roe; Cynthia L Green; Robert P Giugliano; C Michael Gibson; Kenneth W Baran; Mark Greenberg; Sebastian T Palmeri; Suzanne W Crater; Kathleen M Trollinger; Karen L Hannan; Robert A Harrington; Mitchell W Krucoff
Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2004;43(4):549-56.
2004: Stephen D Wiviott; Christopher P Cannon; David A Morrow; Sabina A Murphy; C Michael Gibson; Carolyn H McCabe; Marc S Sabatine; Nader Rifai; Robert P Giugliano; Peter M DiBattiste; Laura A Demopoulos; Elliott M Antman; Eugene Braunwald
Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy.
Circulation 2004;109(5):580-6.
2003: Hans-Peter Hobbach; C Michael Gibson; Robert P Giugliano; Julia Hundertmark; Christel Schaeffer; Wassillij Tscherleniak; Peter Schuster
The prognostic value of serum creatinine on admission in fibrinolytic-eligible patients with acute myocardial infarction.
Journal of thrombosis and thrombolysis 2003;16(3):167-74.
2003: C Michael Gibson; Duane S Pinto; Sabina A Murphy; David A Morrow; Hans-Peter Hobbach; Stephen D Wiviott; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Eugene Braunwald
Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality.
Journal of the American College of Cardiology 2003;42(9):1535-43.
2003: Juhana Karha; Sabina A Murphy; Ajay J Kirtane; James A de Lemos; Julian M Aroesty; Christopher P Cannon; Elliott M Antman; Eugene Braunwald; C Michael Gibson
Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction.
The American journal of cardiology 2003;92(8):913-8.
2003: Nerea Varo; James A de Lemos; Peter Libby; David A Morrow; Sabina A Murphy; Rebecca Nuzzo; C Michael Gibson; Christopher P Cannon; Eugene Braunwald; Uwe Schönbeck
Soluble CD40L: risk prediction after acute coronary syndromes.
Circulation 2003;108(9):1049-52.
2003: C Michael Gibson; William Gibson; Sabina A Murphy; Susan J Marble; Carolyn H McCabe; Minang P Turakhia; Ajay J Kirtane; Juhana Karha; Julian M Aroesty; Robert P Giugliano; Elliott M Antman
Association of the Fibonacci Cascade with the distribution of coronary artery lesions responsible for ST-segment elevation myocardial infarction.
The American journal of cardiology 2003;92(5):595-7.
2003: C Michael Gibson; Juhana Karha; Sabina A Murphy; David James; David A Morrow; Christopher P Cannon; Robert P Giugliano; Elliott M Antman; Eugene Braunwald
Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials.
Journal of the American College of Cardiology 2003;42(1):7-16.
2003: Sabina A Murphy; Kent W Dauterman; James A de Lemos; Sarah Kermgard; Elliott M Antman; Eugene Braunwald; C Michael Gibson
Angiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trial.
American heart journal 2003;146(1):42-7.
2003: C Michael Gibson; Ajay J Kirtane; Sabina A Murphy; Juhana Karha; Christopher P Cannon; Robert P Giugliano; Matthew T Roe; Robert A Harrington; Erik Ohman; Elliott M Antman
Distance from the coronary ostium to the culprit lesion in acute ST-elevation myocardial infarction and its implications regarding the potential prevention of proximal plaque rupture.
Journal of thrombosis and thrombolysis 2003;15(3):189-96.
2003: Graham C Wong; Daniel Frisch; Sabina A Murphy; Marc S Sabatine; Rupal Pai; David James; Nicole Kraimer; Peter T Katsiyiannis; Susan J Marble; Peter M DiBattiste; Laura A Demopoulos; Steven G Gourlay; Hal V Barron; Christopher P Cannon; C Michael Gibson
Time for contrast material to traverse the epicardial artery and the myocardium in ST-segment elevation acute myocardial infarction versus unstable angina pectoris/non-ST-elevation acute myocardial infarction.
The American journal of cardiology 2003;91(10):1163-7.
2003: Daniel R Guerra; Juhana Karha; C Michael Gibson
Safety and efficacy of tenecteplase in acute myocardial infarction.
Expert opinion on pharmacotherapy 2003;4(5):791-8.
2003: M Imran Dotani; Anthony P Morise; Reyaz U Haque; Abnash C Jain; Naresh Gupta; C Michael Gibson
Association between short-term simvastatin therapy before coronary artery bypass grafting and postoperative myocardial blood flow as assessed by positron emission tomography.
The American journal of cardiology 2003;91(9):1107-9.
2003: David A Morrow; James A de Lemos; Marc S Sabatine; Sabina A Murphy; Laura A Demopoulos; Peter M DiBattiste; Carolyn H McCabe; C Michael Gibson; Christopher P Cannon; Eugene Braunwald
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.
Journal of the American College of Cardiology 2003;41(8):1264-72.
2003: Robert P Giugliano; Matthew T Roe; Robert A Harrington; C Michael Gibson; Uwe Zeymer; Frans Van de Werf; Kenneth W Baran; Hans-Peter Hobbach; Lynn H Woodlief; Karen L Hannan; Sally Greenberg; Joanne Miller; Michael M Kitt; John Strony; Carolyn H McCabe; Eugene Braunwald; Robert M Califf
Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial.
Journal of the American College of Cardiology 2003;41(8):1251-60.
2003: Timothy D Henry; Brian H Annex; George R McKendall; Michael A Azrin; John J Lopez; Frank J Giordano; P K Shah; James T Willerson; Raymond L Benza; Daniel S Berman; C Michael Gibson; Alex Bajamonde; Amy Chen Rundle; Jennifer Fine; Ted McCluskey
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.
Circulation 2003;107(10):1359-65.
2003: Sabina A Murphy; Christopher Chen; Steven G Gourlay; Raymond J Gibbons; Hal V Barron; C Michael Gibson
Impairment of myocardial perfusion in both culprit and nonculprit arteries in acute myocardial infarction: a LIMIT AMI substudy.
The American journal of cardiology 2003;91(3):325-8.
2003: Raphaëlle Dumaine; Brian Bigelow; Julian M Aroesty; C Michael Gibson
Myocardial reperfusion: its assessment and its relation to clinical outcomes.
The American heart hospital journal 2003;1(2):120-7.
2003: Maria Cecilia Bahit; Christopher P Cannon; Elliott M Antman; Sabina A Murphy; C Michael Gibson; Carolyn H McCabe; Eugene Braunwald
Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry.
American heart journal 2003;145(1):109-17.
2002: C Michael Gibson; James A de Lemos; Sabina A Murphy; Susan J Marble; Kent W Dauterman; Andrew D Michaels; Hal V Barron; Elliott M Antman
Methodologic and clinical validation of the TIMI myocardial perfusion grade in acute myocardial infarction.
Journal of thrombosis and thrombolysis 2002;14(3):233-7.
2002: Marc S Sabatine; David A Morrow; Christopher P Cannon; Sabina A Murphy; Laura A Demopoulos; Peter M DiBattiste; Carolyn H McCabe; Eugene Braunwald; C Michael Gibson
Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy.
Journal of the American College of Cardiology 2002;40(10):1761-8.
2002: Howard A Cooper; James A de Lemos; David A Morrow; Marc S Sabatine; Sabina A Murphy; Carolyn H McCabe; C Michael Gibson; Elliott M Antman; Eugene Braunwald
Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration.
American heart journal 2002;144(5):790-5.
2002: Brad G Angeja; James de Lemos; Sabina A Murphy; Susan J Marble; Elliott M Antman; Christopher P Cannon; Eugene Braunwald; C Michael Gibson
Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy.
American heart journal 2002;144(4):649-56.
2002: Jeffrey J Popma; Nicholas Cox; Karl Eugen Hauptmann; Nicolaus Reifart; Renu Virmani; Khaled Emira; Sabina Murphy; C Michael Gibson; Eberhard Grube
Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2002;57(2):125-34.
2002: Sabina A Murphy; Christopher Chen; Christopher P Cannon; Elliott M Antman; C Michael Gibson
Impact of gender on angiographic and clinical outcomes after fibrinolytic therapy in acute myocardial infarction.
The American journal of cardiology 2002;90(7):766-70.
2002: Benjamin M Scirica; Christopher P Cannon; C Michael Gibson; Sabina A Murphy; David J Moliterno; H Vernon Anderson; FV Aguirre; Christopher B Granger; Costas T Lambrew; LeRoy E Rabbani; Shelly K Sapp; Joan E Booth; James J Ferguson; Eugene Braunwald
Assessing the effect of publication of clinical guidelines on the management of unstable angina and non-ST elevation myocardial infarction in the TIMI III (1990-1993) and the GUARANTEE (1995-1996) Registries.
Critical pathways in cardiology 2002;1(3):150-8.
2002: Benjamin M Scirica; Christopher P Cannon; Elliott M Antman; Sabina A Murphy; David A Morrow; Marc S Sabatine; Carolyn H McCabe; C Michael Gibson; Eugene Braunwald
Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry.
The American journal of cardiology 2002;90(3):303-5.
2002: Graham C Wong; David A Morrow; Sabina Murphy; Nicole Kraimer; Rupal Pai; David James; Debbie H Robertson; Laura A Demopoulos; Peter M DiBattiste; Christopher P Cannon; C Michael Gibson
Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction.
Circulation 2002;106(2):202-7.
2002: C Michael Gibson; M Imran Dotani; Sabina A Murphy; Susan J Marble; Kent W Dauterman; Andrew D Michaels; J Theodore Dodge
Correlates of coronary blood flow before and after percutaneous coronary intervention and their relationship to angiographic and clinical outcomes in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.
American heart journal 2002;144(1):130-5.
2002: Maria Cecilia Bahit; Sabina A Murphy; C Michael Gibson; Christopher P Cannon
Critical pathway for acute ST-segment elevation myocardial infarction: estimating its potential impact in the TIMI 9 Registry.
Critical pathways in cardiology 2002;1(2):107-12.
2002: Brad G Angeja; Sarah Kermgard; Michael S Chen; Matthew McKay; Sabina A Murphy; Elliott M Antman; Christopher P Cannon; Eugene Braunwald; C Michael Gibson
The smoker's paradox: insights from the angiographic substudies of the TIMI trials.
Journal of thrombosis and thrombolysis 2002;13(3):133-9.
2002: Elliott M Antman; Howard A Cooper; C Michael Gibson; James A de Lemos; Carolyn H McCabe; Robert P Giugliano; P Coussement; S Murphy; J Scherer; K Anderson; Frans Van de Werf; Eugene Braunwald
Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II.
European heart journal 2002;23(12):928-33.
2002: Andrew D Michaels; Mark Appleby; Matthew H Otten; Kent W Dauterman; Thomas A Ports; Tony M Chou; C Michael Gibson
Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial.
The Journal of invasive cardiology 2002;14(6):299-302.
2002: Brad G Angeja; C Michael Gibson; Richard Chin; Paul D Frederick; Nathan R Every; Allan M Ross; Gregg W Stone; Hal V Barron
Predictors of door-to-balloon delay in primary angioplasty.
The American journal of cardiology 2002;89(10):1156-61.
2002: C Michael Gibson; Christopher P Cannon; Sabina A Murphy; Susan J Marble; Hal V Barron; Eugene Braunwald
Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction.
Circulation 2002;105(16):1909-13.
2002: Marc S Sabatine; David A Morrow; James A de Lemos; C Michael Gibson; Sabina A Murphy; Nader Rifai; Carolyn McCabe; Elliott M Antman; Christopher P Cannon; Eugene Braunwald
Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.
Circulation 2002;105(15):1760-3.
2002: Elliott M Antman; Hans W Louwerenburg; Hubert F Baars; Jan C L Wesdorp; Bas Hamer; Jean-Pierre Bassand; Frederique Bigonzi; Ghislaine Pisapia; C Michael Gibson; Hein Heidbuchel; Eugene Braunwald; Frans Van de Werf
Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial.
Circulation 2002;105(14):1642-9.
2002: C Michael Gibson; Daniel Frisch; Sabina A Murphy; Steven G Gourlay; Raymond Gibbons; Kenneth W Baran; Michel Nguyen; Sebastian T Palmeri; Hal V Barron
The relationship of intracoronary stent placement following thrombolytic therapy to tissue level perfusion.
Journal of thrombosis and thrombolysis 2002;13(2):63-8.
2002: Christopher P Cannon; Maria Cecilia Bahit; J Mark Haugland; Timothy D Henry; Marc J Schweiger; George R McKendall; Prediman K Shah; Sabina Murphy; C Michael Gibson; Carolyn H McCabe; Elliott M Antman; Eugene Braunwald
Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry.
Critical pathways in cardiology 2002;1(1):44-52.
2002: C Michael Gibson; Michael Chen; Brad G Angeja; Sabina A Murphy; Susan J Marble; Hal V Barron; Christopher P Cannon
Precordial ST-segment depression in inferior myocardial infarction is associated with slow flow in the non-culprit left anterior descending artery.
Journal of thrombosis and thrombolysis 2002;13(1):9-12.
2002: Daniel H Solomon; David A Ganz; Jerry Avorn; Robert J Glynn; Eric L Knight; C Michael Gibson; Peter H Stone
Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapy.
Journal of clinical epidemiology 2002;55(2):121-8.
2002: Brad G Angeja; Madhavi Gunda; Sabina A Murphy; Burton E Sobel; Amy Chen Rundle; Mushabbar A Syed; Abdelrahim Asfour; Steven Borzak; Steven G Gourlay; Hal V Barron; Raymond J Gibbons; C Michael Gibson
TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging.
Circulation 2002;105(3):282-5.
2002: C Michael Gibson; Sabina A Murphy; Susan J Marble; David J Cohen; Eric A Cohen; Henry K Lui; Jeffrey Young; Michael M Kitt; Todd J Lorenz; James E Tcheng
Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy.
American heart journal 2002;143(1):106-10.
2001: Kenneth W Baran; M Nguyen; George R McKendall; Costas T Lambrew; G Dykstra; S T Palmeri; Raymond J Gibbons; Steven Borzak; Burton E Sobel; Steven G Gourlay; Amy Chen Rundle; C Michael Gibson; Hal V Barron
Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study.
Circulation 2001;104(23):2778-83.
2001: Brad G Angeja; J H Alexander; Richard Chin; X Li; Hal V Barron; P W Armstrong; C B Granger; F Van de Werf; C Michael Gibson
Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-Trial.
The American journal of cardiology 2001;88(11):1240-5.
2001: Daniel H Solomon; Peter H Stone; Robert J Glynn; David A Ganz; C Michael Gibson; R Tracy; Jerry Avorn
Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy.
Journal of the American College of Cardiology 2001;38(4):969-76.
2001: C Michael Gibson; Susan J Marble
Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA).
Clinical cardiology 2001;24(9):577-84.
2001: James A de Lemos; David A Morrow; C Michael Gibson; Sabina A Murphy; Nader Rifai; M Tanasijevic; Robert P Giugliano; Kristin C Schuhwerk; Carolyn H McCabe; C P Cannon; Elliott M Antman; Eugene Braunwald
Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy.
The American journal of cardiology 2001;88(4):353-8.
2001: Christopher P Cannon; William S Weintraub; Laura A Demopoulos; R Vicari; MJ Frey; Nasser Lakkis; Franz-Josef Neumann; Debbie H Robertson; Paul T DeLucca; Peter M DiBattiste; C Michael Gibson; Eugene Braunwald
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
The New England journal of medicine 2001;344(25):1879-87.
2001: C Michael Gibson; David J Cohen; Eric A Cohen; Henry K Lui; Sabina A Murphy; Susan J Marble; Michael M Kitt; Todd J Lorenz; James E Tcheng
Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy.
The American journal of cardiology 2001;87(11):1293-5.
2001: C Michael Gibson; J A de Lemos; Sabina A Murphy; Susan J Marble; Carolyn H McCabe; C P Cannon; E M Antman; E Braunwald
Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy.
Circulation 2001;103(21):2550-4.
2001: C Michael Gibson; Ajay J Kirtane; Sabina A Murphy; Susan J Marble; J A de Lemos; E M Antman; E Braunwald
Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2001;53(1):6-11.
2001: James A de Lemos; C Michael Gibson; Elliott M Antman; Sabina A Murphy; David A Morrow; Kristin C Schuhwerk; M Schweiger; P Coussement; Frans Van de Werf; Eugene Braunwald
Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial.
American heart journal 2001;141(4):592-8.
2001: Brad G Angeja; C Michael Gibson; Richard Chin; John G Canto; Hal V Barron
Use of reperfusion therapies in elderly patients with acute myocardial infarction.
Drugs & aging 2001;18(8):587-96.
2001: F Wang-Clow; NL Fox; Christopher P Cannon; C Michael Gibson; S Berioli; Erich Bluhmki; Thierry Danays; Eugene Braunwald; Frans Van de Werf; D C Stump
Determination of a weight-adjusted dose of TNK-tissue plasminogen activator.
American heart journal 2001;141(1):33-40.
2000: C Michael Gibson; M Anshelevich; S Murphy; L Luu; C Hynes; J Kliris; S Kermgard; M H Otten; Elliott M Antman; Christopher P Cannon; Eugene Braunwald
Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction.
The American journal of cardiology 2000;86(12):1378-9, A5.
2000: C Michael Gibson; M Goel; Sabina A Murphy; I Dotani; Susan J Marble; LI Deckelbaum; J Theodore Dodge; S B King
Global impairment of coronary blood flow in the setting of acute coronary syndromes (a RESTORE substudy). Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis.
The American journal of cardiology 2000;86(12):1375-7, A5.
2000: Elliott M Antman; C Michael Gibson; James A de Lemos; Robert P Giugliano; Carolyn H McCabe; P Coussement; Ian B A Menown; Christoph A Nienaber; T C Rehders; MJ Frey; R Van der Wieken; Dietrich Andresen; J Scherer; K Anderson; Frans Van de Werf; Eugene Braunwald
Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators.
European heart journal 2000;21(23):1944-53.
2000: M Imran Dotani; D Michael Elnicki; Abnash C Jain; C Michael Gibson
Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting.
The American journal of cardiology 2000;86(10):1128-30, A6.
2000: Hal V Barron; Christopher P Cannon; Sabina A Murphy; Eugene Braunwald; C Michael Gibson
Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy.
Circulation 2000;102(19):2329-34.
2000: James C Fang; Scott Kinlay; P Wexberg; A Amirzadeh; C Michael Gibson; Andrew P Selwyn; Peter Ganz
Use of the thrombolysis in myocardial infarction frame count for the quantitative assessment of transplant-associated arteriosclerosis.
The American journal of cardiology 2000;86(8):890-2.
2000: James A de Lemos; Elliott M Antman; David A Morrow; J Llevadot; Robert P Giugliano; SA Coulter; Kristin C Schuhwerk; S Arslanian; Carolyn H McCabe; C Michael Gibson; Nader Rifai
Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy.
Clinica chimica acta; international journal of clinical chemistry 2000;298(1-2):85-97.
2000: J Llevadot; Robert P Giugliano; Carolyn H McCabe; Christopher P Cannon; Elliott M Antman; S Murphy; C Michael Gibson
Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials).
The American journal of cardiology 2000;85(12):1409-13.
2000: Christopher P Cannon; C Michael Gibson; Costas T Lambrew; DA Shoultz; D Levy; William J French; Joel M Gore; W D Weaver; W J Rogers; Alan J Tiefenbrunn
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction.
JAMA : the journal of the American Medical Association 2000;283(22):2941-7.
2000: SA Coulter; Christopher P Cannon; K A Ault; Elliott M Antman; Frans Van de Werf; A A Jennifer Adgey; C Michael Gibson; Robert P Giugliano; Mary Ann Mascelli; J Scherer; Elliot S Barnathan; Eugene Braunwald; N S Kleiman
High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14.
Circulation 2000;101(23):2690-5.
2000: Andrew D Michaels; C Michael Gibson; Hal V Barron
Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon.
The American journal of cardiology 2000;85(5A):50B-60B.
2000: James A de Lemos; Elliott M Antman; Robert P Giugliano; Carolyn H McCabe; Sabina A Murphy; Frans Van de Werf; C Michael Gibson; Eugene Braunwald
ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators.
The American journal of cardiology 2000;85(3):299-304.
2000: James A de Lemos; Elliott M Antman; C Michael Gibson; Carolyn H McCabe; Robert P Giugliano; Sabina A Murphy; SA Coulter; K Anderson; J Scherer; MJ Frey; R Van der Wieken; Frans Van de Werf; Eugene Braunwald
Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial.
Circulation 2000;101(3):239-43.
2000: C Michael Gibson; Christopher P Cannon; Sabina A Murphy; KA Ryan; R Mesley; Susan J Marble; Carolyn H McCabe; Frans Van de Werf; Eugene Braunwald
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs.
Circulation 2000;101(2):125-30.
1999: C Michael Gibson; Christopher P Cannon; Sabina A Murphy; A A Adgey; MJ Schweiger; Rafael Sequeira; G Grollier; NL Fox; S Berioli; W D Weaver; Frans Van de Werf; Eugene Braunwald
Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B Investigators.
The American journal of cardiology 1999;84(9):976-80.
1999: C Michael Gibson; S Murphy; Ian B A Menown; Rafael Sequeira; R Greene; Frans Van de Werf; M J Schweiger; M Ghali; MJ Frey; KA Ryan; Susan J Marble; Robert P Giugliano; Elliott M Antman; Christopher P Cannon; Eugene Braunwald
Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction.
Journal of the American College of Cardiology 1999;34(5):1403-12.
1999: C Michael Gibson; KA Ryan; Sabina A Murphy; R Mesley; Susan J Marble; Robert P Giugliano; Christopher P Cannon; Elliott M Antman; Eugene Braunwald
Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction.
Journal of the American College of Cardiology 1999;34(4):974-82.
1999: Milenko J Tanasijevic; Christopher P Cannon; Elliott M Antman; DR Wybenga; George A Fischer; C Grudzien; C Michael Gibson; James W Winkelman; Eugene Braunwald
Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B.
Journal of the American College of Cardiology 1999;34(3):739-47.
1999: C Michael Gibson; J L Moynihan; EN Al-Mousa; M Campsey; R Gandhi; S Murphy; S Mattson; KA Ryan; R Mesley; J Swanson; M N Arshad; Susan J Marble
Glycoprotein IIb/IIIa receptor inhibition in interventional cardiology.
Journal of thrombosis and thrombolysis 1999;7(3):287-302.
1999: Elliott M Antman; Robert P Giugliano; C Michael Gibson; Carolyn H McCabe; P Coussement; N S Kleiman; A Vahanian; A A Jennifer Adgey; Ian B A Menown; H J Rupprecht; R Van der Wieken; J Ducas; J Scherer; K Anderson; Frans Van de Werf; Eugene Braunwald
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators.
Circulation 1999;99(21):2720-32.
1999: C Michael Gibson; KA Ryan; M Kelley; MJ Rizzo; R Mesley; S Murphy; J Swanson; Susan J Marble; J Theodore Dodge; Robert P Giugliano; Christopher P Cannon; Elliott M Antman
Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. The TIMI Study Group.
American heart journal 1999;137(6):1179-84.
1999: C Michael Gibson
Primary angioplasty compared with thrombolysis: new issues in the era of glycoprotein IIb/IIIa inhibition and intracoronary stenting.
Annals of internal medicine 1999;130(10):841-7.
1999: C Michael Gibson; Sabina A Murphy; MJ Rizzo; KA Ryan; Susan J Marble; Carolyn H McCabe; Christopher P Cannon; Frans Van de Werf; Eugene Braunwald
Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group.
Circulation 1999;99(15):1945-50.
1999: C Michael Gibson; K Ryan; A Sparano; J L Moynihan; M Rizzo; M Kelley; Susan J Marble; R Laham; M Simons; T R McClusky; J Theodore Dodge
Angiographic methods to assess human coronary angiogenesis.
American heart journal 1999;137(1):169-79.
1998: Christopher P Cannon; C Michael Gibson; Carolyn H McCabe; A A Adgey; M J Schweiger; Rafael Sequeira; G Grollier; Robert P Giugliano; M Frey; HS Mueller; Richard M Steingart; W D Weaver; Frans Van de Werf; Eugene Braunwald
TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.
Circulation 1998;98(25):2805-14.
1998: C Michael Gibson; M Goel; D J Cohen; R N Piana; LI Deckelbaum; K E Harris; S B King
Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis.
Journal of the American College of Cardiology 1998;32(1):28-34.
1998: J Theodore Dodge; M Rizzo; M Nykiel; J Altmann; K Hobkirk; M Brennan; C Michael Gibson
Impact of injection rate on the Thrombolysis in Myocardial Infarction (TIMI) trial frame count.
The American journal of cardiology 1998;81(10):1268-70.
1998: J Theodore Dodge; M Nykiel; J Altmann; K Hobkirk; M Brennan; C Michael Gibson
Coronary artery injection technique: a quantitative in vivo investigation using modern catheters.
Catheterization and cardiovascular diagnosis 1998;44(1):34-9.
1998: EN Al-Mousa; J Theodore Dodge; M Rizzo; C McLean; K Ryan; J Moynihan; M Kelley; Susan J Marble; M Goel; W L Daley; C Michael Gibson
Thrombolysis in Myocardial Infarction frame count in saphenous vein grafts.
American heart journal 1998;135(2 Pt 1):323-8.
1997: C Michael Gibson; J Theodore Dodge; M Goel; EN Al-Mousa; M Rizzo; C McLean; K Ryan; A Sparano; Susan J Marble; W L Daley; Christopher P Cannon; Elliott M Antman
Angioplasty guidewire velocity: a new simple method to calculate absolute coronary blood velocity and flow.
The American journal of cardiology 1997;80(12):1536-9.
1997: Milenko J Tanasijevic; Christopher P Cannon; DR Wybenga; George A Fischer; C Grudzien; C Michael Gibson; James W Winkelman; Elliott M Antman; Eugene Braunwald
Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A.
American heart journal 1997;134(4):622-30.
1997: C Michael Gibson; Susan J Marble; MJ Rizzo; J Moynihan; C McLean; K Ryan; A Sparano; Robert N Piana; C McCabe; Christopher P Cannon
Relation between injections before 90-minute angiography and coronary patency: results of the thrombolysis in myocardial infarction 4 trial.
American heart journal 1997;134(3):351-4.
1997: C Michael Gibson; Christopher P Cannon; R M Greene; Rafael Sequeira; R D Margorien; F Leya; DJ Diver; Donald S Baim; Eugene Braunwald
Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial.
The American journal of cardiology 1997;80(1):21-6.
1997: Christopher P Cannon; Carolyn H McCabe; C Michael Gibson; M Ghali; Rafael Sequeira; G R McKendall; J Breed; N B Modi; NL Fox; R P Tracy; T W Love; Eugene Braunwald
TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial.
Circulation 1997;95(2):351-6.
1996: R C Pasternak; L E Brown; Peter H Stone; D I Silverman; C Michael Gibson; F M Sacks
Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
Annals of internal medicine 1996;125(7):529-40.
1996: C Michael Gibson; Christopher P Cannon; W L Daley; J Theodore Dodge; B Alexander; Susan J Marble; Carolyn H McCabe; L Raymond; T Fortin; W K Poole; Eugene Braunwald
TIMI frame count: a quantitative method of assessing coronary artery flow.
Circulation 1996;93(5):879-88.
1995: Frank M Sacks; C Michael Gibson; B Rosner; R C Pasternak; Peter H Stone
The influence of pretreatment low density lipoprotein cholesterol concentrations on the effect of hypocholesterolemic therapy on coronary atherosclerosis in angiographic trials. Harvard Atherosclerosis Reversibility Project Research Group.
The American journal of cardiology 1995;76(9):78C-85C.
1995: Frank M Sacks; Peter H Stone; C Michael Gibson; D I Silverman; B Rosner; R C Pasternak
Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group.
Journal of the American College of Cardiology 1995;25(7):1492-8.
1995: C Michael Gibson; Christopher P Cannon; Robert N Piana; JA Breall; Barry L Sharaf; M Flatley; B Alexander; DJ Diver; Carolyn H McCabe; Greg C Flaker
Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
Journal of the American College of Cardiology 1995;25(3):582-9.
1994: Frank M Sacks; R C Pasternak; C Michael Gibson; B Rosner; Peter H Stone
Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. Harvard Atherosclerosis Reversibility Project (HARP) Group.
Lancet 1994;344(8931):1182-6.
1994: Waqar Ahmed; S J Shubrooks; C Michael Gibson; D S Baim; John A Bittl
Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients.
American heart journal 1994;128(2):252-5.
1994: P C Gordon; S P Friedrich; Robert N Piana; A D Kugelmass; G A Leidig; C Michael Gibson; David J Cohen; Joseph P Carrozza; Richard E Kuntz; Donald S Baim
Is 40% to 70% diameter narrowing at the site of previous stenting or directional coronary atherectomy clinically significant?
The American journal of cardiology 1994;74(1):26-32.
1994: Robert N Piana; G Y Paik; Mauro Moscucci; David J Cohen; C Michael Gibson; A D Kugelmass; Joseph P Carrozza; Richard E Kuntz; Donald S Baim
Incidence and treatment of 'no-reflow' after percutaneous coronary intervention.
Circulation 1994;89(6):2514-8.
1993: C Michael Gibson; Richard E Kuntz; M Nobuyoshi; B Rosner; Donald S Baim
Lesion-to-lesion independence of restenosis after treatment by conventional angioplasty, stenting, or directional atherectomy. Validation of lesion-based restenosis analysis.
Circulation 1993;87(4):1123-9.
1993: P C Gordon; C Michael Gibson; David J Cohen; Joseph P Carrozza; Richard E Kuntz; Donald S Baim
Mechanisms of restenosis and redilation within coronary stents--quantitative angiographic assessment.
Journal of the American College of Cardiology 1993;21(5):1166-74.
1993: Peter H Stone; C Michael Gibson; R C Pasternak; K McManus; L Diaz; T Boucher; R Spears; T Sandor; B Rosner; Frank M Sacks
Natural history of coronary atherosclerosis using quantitative angiography in men, and implications for clinical trials of coronary regression. The Harvard Atherosclerosis Reversibility Project Study Group.
The American journal of cardiology 1993;71(10):766-72.
1993: C Michael Gibson; L Diaz; K Kandarpa; Frank M Sacks; R C Pasternak; T Sandor; C Feldman; Peter H Stone
Relation of vessel wall shear stress to atherosclerosis progression in human coronary arteries.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(2):310-5.
1993: Richard E Kuntz; C Michael Gibson; M Nobuyoshi; Donald S Baim
Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy.
Journal of the American College of Cardiology 1993;21(1):15-25.
1992: Joseph P Carrozza; Richard E Kuntz; M J Levine; R M Pomerantz; R F Fishman; M Mansour; C Michael Gibson; C C Senerchia; DJ Diver; Robert D Safian
Angiographic and clinical outcome of intracoronary stenting: immediate and long-term results from a large single-center experience.
Journal of the American College of Cardiology 1992;20(2):328-37.
1992: C Michael Gibson; T Sandor; Peter H Stone; R C Pasternak; B Rosner; Frank M Sacks
Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials.
The American journal of cardiology 1992;69(16):1286-90.